Google parent company shopping around shoes that track weight and falls

Verily, the life sciences business of Google parent company Alphabet, has a new prototype for shoes enabled with sensors that can help track weight, falls and movement, according to CNBC.

Verily has reportedly been looking for partners to develop the shoes, showing a prototype in private meetings in the hopes of bringing them to market, three people familiar with the project told CNBC.

The project is the latest example of the arms race in digital health from major companies, such as Apple and Amazon. Verily’s Study Watch recently earned FDA clearance for its electrocardiogram (ECG) feature. The Alphabet subsidiary also raised $1 billion in an investment round at the start of the year.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.